Drug profile · INN
inotersen sodium
TEGSEDI
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
inotersen sodium (TEGSEDI) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
Key facts
INN inotersen sodium
Brand TEGSEDI
Route SUBCUTANEOUS
Formulation SOLUTION
Frequently asked questions
What is inotersen sodium?
inotersen sodium (TEGSEDI) is an FDA-listed pharmaceutical active ingredient. Route of administration: subcutaneous. Current US regulatory status: approved.
What is the brand name for inotersen sodium?
TEGSEDI is a marketed brand name for inotersen sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of inotersen sodium?
inotersen sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.